Who we are
At ZBRA Pharma Consulting, we specialize in providing strategic business solutions for the specialty care and rare disease sectors. Our expertise bridges global biotech innovations with the Korean market, helping companies successfully navigate commercialization, regulatory landscapes, and market entry strategies.
With a deep understanding of Korea’s healthcare ecosystem, a robust network of real-world experts (RWE), and a track record of successful market launches, ZBRA BioPharma Consulting is the trusted partner for companies looking to thrive in the specialty care and rare disease space.
What we do
-
Market Entry & Expansion – Helping global biotech firms assess market potential, find the right partners, and launch in Korea, while also assisting domestic pharmaceutical companies in connecting with international partners and consulting firms.
-
End-to-End Commercialization – Acting as a MA holder, overseeing regulatory approval, distribution, and sales execution.
-
Strategic Consulting & Talent Development – Empowering local and multinational pharmaceutical companies with tailored commercial strategies, team structuring, and training programs.
-
Commercial Operations & Partnerships – Offering co-promotion and CSO services, leveraging Key Account Management (KAM) expertise for sales growth.
Chad. Ji
Founder / Managing Partner
As the founder and Manageing Partner of ZBRA Pharma Consulting, I bring over 20 years of experience leading commercialization initiatives in the specialty care and rare disease sectors. I have successfully driven market access, regulatory approvals, and product launches at top-tier companies like Takeda, Shire, and Sanofi-Genzyme, specializing in rare disease treatments, including ultra rare disease and specialty care area.
At ZBRA Pharma Consulting, our vision is to revolutionize rare disease and specialty care market entry through expert-driven, strategic consulting. We empower global biotech and pharmaceutical companies with end-to-end commercialization support, from market entry to operational success. My deep understanding of the Korean pharmaceutical market and a strong network of partners in the rare disease field have been instrumental in navigating complex market entry strategies and securing successful outcomes.
In addition, we focus on building high-performance teams and helping organizations enhance their strategic capabilities for sustainable growth in the rare disease and specialty care sectors
Our MVC
Mission
Empowering global biotech & pharmaceutical companies
with end-to-end commercialization support,
from market entry to operational success.
Vision
Revolutionizing rare disease & specialty care market entry
through expert-driven, strategic consulting.
Core Value
Drive impact in rare disease through our 4S Approach:
🔹 Small: Start with agile market entry with precision.
🔹 Specialized: Focus in deep expertise in rare diseases.
🔹 Sustainable: Growth in long-term viability through regulatory and pricing excellence.
🔹 Scalable: Solutions expanding impact through strategic partnerships.
By integrating market entry, commercialization, regulatory strategy, and partnerships,
we deliver tailored solutions that transform challenges into opportunities.
-
Small
-
Specialized
-
Sustainable
-
Scalable